Email updates

Keep up to date with the latest news and content from Journal of Biomedical Science and BioMed Central.

Journal App

google play app store

MST logoThe cost of publication in Journal of Biomedical Science is borne by the Ministry of Science and Technology, Taiwan.

Open Access Open Badges Research

Recombinant salmonella-based 4-1BBL vaccine enhances T cell immunity and inhibits the development of colorectal cancer in rats: in vivo effects of vaccine containing 4-1BBL

Jianxin Ye1, Ling Li1, Yuanting Zhang1, Xueguang Zhang2, Daming Ren3 and Weichang Chen1*

Author Affiliations

1 Department of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China

2 Institute of Medical Biotechnology, Key Laboratory of Medicine and Clinical Immunology of Jiangsu Province, Soochow University, 215007, Suzhou, China

3 Institute of Genetics, State Key Laboratory of Genetic Engineering of Fudan University, 200433, Shanghai, China

For all author emails, please log on.

Journal of Biomedical Science 2013, 20:8  doi:10.1186/1423-0127-20-8

Published: 17 February 2013



Immunotherapy with vaccines is attractive for the treatment of cancer. This study is aimed at determining the effect of recombinant Salmonella (SL3261)-based 4-1BB ligand (4-1BBL) vaccine on the development of colorectal cancers and the potential immune mechanisms in rats.


In comparison with that in the PBS group, similar levels of 4-1BBL expression, the frequency of T cells, IFN-γ responses, and comparable numbers of tumors were detected in the SL3261 and SL3261C groups of rats. In contrast, significantly fewer numbers of tumors, increased levels of 4-1BBL expression in the spleens and colorectal tissues, higher frequency of peripheral blood and splenic CD3+CD25+ T cells, and stronger splenic T cell IFN-γ responses were detected in the SL3261R group of rats.


Our results indicated that vaccination with recombinant attenuated Salmonella harboring the 4-1BBL gene efficiently enhanced T cell immunity and inhibited the development of carcinogen-induced colorectal cancers in rats.

Recombinant attenuated salmonella; Colorectal cancer; 4-1BBL; T cell-based cellular immunity